EDGAR Filing Documents for 0001213900-19-002926

Form 8-K - Current report:

SEC Accession No. 0001213900-19-002926

Filing Date

2019-02-20

Accepted

2019-02-20 17:00:28

Documents

Period of Report

2019-02-13

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	f8k021319_hoththerapeutics.htm	8-K	42149
2	CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION	f8k021319ex3-1_hoththerap.htm	EX-3.1	41910
3	AMENDED AND RESTATED BYLAWS	f8k021319ex3-2_hoththerap.htm	EX-3.2	127940
4	AMENDED AND RESTATED EMPLOYMENT AGREEMENT, BY AND BETWEEN HOTH THERAPEUTICS, INC	f8k021319ex10-1_hoththerap.htm	EX-10.1	63201
5	PRESS RELEASE, DATED FEBRUARY 15, 2019	f8k021319ex99-1_hoththerap.htm	EX-99.1	8111
6	PRESS RELEASE, DATED FEBRUARY 20, 2019	f8k021319ex99-2_hoththerap.htm	EX-99.2	8366
7	GRAPHIC	ex3-1_001.jpg	GRAPHIC	14072
8	GRAPHIC	ex3-1_002.jpg	GRAPHIC	7897
9	GRAPHIC	ex3-1_003.jpg	GRAPHIC	14410
	Complete submission text file	0001213900-19-002926.txt		343534

Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020

Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261

Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)